TAMRA MOSS: Open Payments
NPI 1912340449 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 21 payments from 12 companies in 2025. Trend: 2023 $522 · 2024 $636 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $60 |
| Novo Nordisk Inc | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $28 |
| Lundbeck LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Auvelity, REXULTI, OTEZLA, FARXIGA, VOQUEZNA, FANAPT, SHINGRIX, Ozempic.
Industry payments across KY — which companies pay providers there.
